Tactile Systems Technology, Inc. Common Stock TCMD
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-12T01:43:22.933Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:05.360595994Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T01:43:22.436288+00:00
Tactile Systems Technology, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 21.86 | 201.8% | 23.4% | |||
| 25Δ | 23.49 | 164.9% | 17.7% | |||
| 30Δ | 28.75 | 52.5% | 8.5% | 24.83 | 136.2% | 13.0% |
| 35Δ | 28.41 | 52.7% | 7.8% | 25.43 | 126.8% | 11.4% |
| 40Δ | 28.06 | 52.9% | 7.1% | 25.93 | 120.4% | 10.3% |
| 45Δ | 27.72 | 53.0% | 6.4% | 26.42 | 114.0% | 9.1% |
| 50Δ | 27.37 | 53.2% | 5.7% | 26.92 | 107.6% | 8.0% |
| 55Δ | 27.03 | 53.4% | 5.0% | 27.41 | 101.2% | 6.9% |
| 60Δ | 26.68 | 53.5% | 4.3% | 27.91 | 94.8% | 5.7% |
| 65Δ | 26.34 | 53.7% | 3.6% | 28.40 | 88.4% | 4.6% |
| 70Δ | 26.00 | 53.8% | 2.8% | 28.90 | 82.0% | 3.5% |
| 75Δ | 25.65 | 54.0% | 2.1% | 29.39 | 75.6% | 2.3% |
| 80Δ | 25.31 | 54.2% | 1.4% | 29.89 | 69.2% | 1.2% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 21.86
- IV
- 201.8%
- B/E move
- 23.4%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 23.49
- IV
- 164.9%
- B/E move
- 17.7%
30Δ
- Pseudo strike
- 28.75
- IV
- 52.5%
- B/E move
- 8.5%
- Pseudo strike
- 24.83
- IV
- 136.2%
- B/E move
- 13.0%
35Δ
- Pseudo strike
- 28.41
- IV
- 52.7%
- B/E move
- 7.8%
- Pseudo strike
- 25.43
- IV
- 126.8%
- B/E move
- 11.4%
40Δ
- Pseudo strike
- 28.06
- IV
- 52.9%
- B/E move
- 7.1%
- Pseudo strike
- 25.93
- IV
- 120.4%
- B/E move
- 10.3%
45Δ
- Pseudo strike
- 27.72
- IV
- 53.0%
- B/E move
- 6.4%
- Pseudo strike
- 26.42
- IV
- 114.0%
- B/E move
- 9.1%
50Δ
- Pseudo strike
- 27.37
- IV
- 53.2%
- B/E move
- 5.7%
- Pseudo strike
- 26.92
- IV
- 107.6%
- B/E move
- 8.0%
55Δ
- Pseudo strike
- 27.03
- IV
- 53.4%
- B/E move
- 5.0%
- Pseudo strike
- 27.41
- IV
- 101.2%
- B/E move
- 6.9%
60Δ
- Pseudo strike
- 26.68
- IV
- 53.5%
- B/E move
- 4.3%
- Pseudo strike
- 27.91
- IV
- 94.8%
- B/E move
- 5.7%
65Δ
- Pseudo strike
- 26.34
- IV
- 53.7%
- B/E move
- 3.6%
- Pseudo strike
- 28.40
- IV
- 88.4%
- B/E move
- 4.6%
70Δ
- Pseudo strike
- 26.00
- IV
- 53.8%
- B/E move
- 2.8%
- Pseudo strike
- 28.90
- IV
- 82.0%
- B/E move
- 3.5%
75Δ
- Pseudo strike
- 25.65
- IV
- 54.0%
- B/E move
- 2.1%
- Pseudo strike
- 29.39
- IV
- 75.6%
- B/E move
- 2.3%
80Δ
- Pseudo strike
- 25.31
- IV
- 54.2%
- B/E move
- 1.4%
- Pseudo strike
- 29.89
- IV
- 69.2%
- B/E move
- 1.2%
Options history
Table
| Date | IV (%) |
|---|---|
| 64.35% | |
| 65.31% | |
| 65.47% | |
| 69.14% | |
| 68.62% | |
| 68.40% | |
| 73.86% | |
| 71.30% | |
| 69.26% | |
| 76.62% |
Medical Devices
TLSI
TriSalus Life Sciences Inc. (TLSI) is an innovative biopharmaceutical firm at the forefront of enhancing cancer therapy through its proprietary localized drug delivery systems,…
More →TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and…
More →TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the…
More →TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company…
More →TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the…
More →UFPT
Description unavailable
More →